NEO · Healthcare

Biomind Labs Inc (BMND)

Biotechnology

Biomind Labs Inc (BMND) is listed on NEO in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BMND

P/E ratio

25.00

Biomind Labs Inc (BMND) — FAQ

What is BMND's P/E ratio?

The price-to-earnings (P/E) ratio for Biomind Labs Inc (BMND) is 25.00 (data as of 2026-05-24).

Does Biomind Labs Inc pay a dividend?

Dividend yield is not available in the current snapshot for Biomind Labs Inc (BMND). Check the MyAverix Finance app for the latest dividend data.

What sector is Biomind Labs Inc in?

Biomind Labs Inc (BMND) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BMND listed on?

BMND is listed on NEO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)